Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 11 - ‘This New Inoculation Is No Sham!’

  • Michael Bennett, University of Tasmania
  • Book:
    War Against Smallpox
    Published online:
    22 May 2020
    Print publication:
    18 June 2020, pp 267-294

  • Summary

    Chapter 11 discusses the early vaccination in North America. Dr Benjamin Waterhouse pioneered the practice in Boston in August 1800, rebranded cowpox as kinepox and briefly enjoyed a monopoly of the practice. Aware of the hazards associated with smallpox inoculation, Americans welcomed the new prophylaxis. President Thomson Jefferson took up the lancet at Monticello and, largely in a private capacity, helped to entrench and extend the practice. Philadelphia emerged as a new hub of vaccination, seeding its establishment in the southern states and on the western frontier. Serviceable to individuals and communities, the new practice served to bind together the new nation, with slaves often among the first to be vaccinated and prophylaxis being offered, as opportunities arose, to Native Americans. The problem of maintaining a supply of good vaccine in sparsely populated districts and on the frontier appeared more urgent with the outbreak of war with Britain in 1812 and explains the Federal government’s unusual decision to fund a (short-lived) National Vaccine Agency in Baltimore.